Experimental Ebola drugs must be fairly distributed, tested ethically in clinical trials

Critical ethical principles need to be adhered to if experimental drugs are to be deployed in the Ebola outbreak, bioethicists say, stating that the patients selected to receive such drugs must not be limited to well-off or well-connected patients -- including health care professionals. These experts also point out that, given the limited supply of experimental drugs and their low probability of success, containment of the epidemic and strengthening health systems in affected regions should be a priority.

Read the whole article on Science Daily

More from Science Daily